Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HF
951
DELISTED
HFF Inc.
HF
| $15.3M | 0.02% |
505,000
+22,200
| +5% | +$633K |
|
|
FFKT
952
DELISTED
Farmers Capital Bank Corp
FFKT
| $15.3M | 0.02% |
363,100
+106,600
| +42% | +$3.73M |
|
|
CSR
953
Centerspace
CSR
$925M
| $15.2M | 0.02% |
213,440
-7,490
| -3% | -$475K |
|
954
Novanta
NOVT
$6.32B
| $15.2M | 0.02% |
724,200
+10,700
| +1% | +$204K |
|
|
WNR
955
DELISTED
Western Refining Inc
WNR
| $15.2M | 0.02% |
401,600
-152,600
| -28% | -$5.02M |
|
|
HMSY
956
DELISTED
HMS Holdings Corp.
HMSY
| $15.2M | 0.02% |
835,700
-15,900
| -2% | -$309K |
|
|
ACC
957
DELISTED
American Campus Communities, Inc.
ACC
| $15.2M | 0.02% |
304,600
-154,300
| -34% | -$7.44M |
|
|
BPFH
958
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $15.1M | 0.02% |
914,600
-71,400
| -7% | -$1.03M |
|
959
WaFd
WAFD
$2.79B
| $15.1M | 0.02% |
440,200
-14,600
| -3% | -$446K |
|
960
Jefferies Financial Group
JEF
$12.9B
| $15.1M | 0.02% |
+726,456
| New | +$13.6M |
|
961
Hooker Furnishings Corp
HOFT
$158M
| $15.1M | 0.02% |
398,365
+144,500
| +57% | +$4.16M |
|
|
CVGW
962
DELISTED
Calavo Growers
CVGW
| $15M | 0.02% |
244,520
+157,800
| +182% | +$9.6M |
|
|
CHFN
963
DELISTED
Charter Financial Corp
CHFN
| $15M | 0.02% |
900,259
-9,900
| -1% | -$139K |
|
|
QGENF
964
DELISTED
QIAGEN NV
QGENF
| $15M | 0.02% |
535,400
+345,400
| +182% | +$9.68M |
|
|
ZIXI
965
DELISTED
Zix Corporation
ZIXI
| $15M | 0.02% |
3,036,400
+79,300
| +3% | +$350K |
|
|
CLCT
966
DELISTED
Collectors Universe
CLCT
| $15M | 0.02% |
705,519
-24,600
| -3% | -$490K |
|
|
CACB
967
DELISTED
Cascade Bancorp
CACB
| $15M | 0.02% |
1,842,507
+946,800
| +106% | +$6.57M |
|
968
Commercial Metals
CMC
$7.98B
| $14.9M | 0.02% |
686,400
+374,000
| +120% | +$7.34M |
|
|
MSCC
969
DELISTED
Microsemi Corp
MSCC
| $14.9M | 0.02% |
277,001
-19,800
| -7% | -$967K |
|
|
ARRS
970
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $14.9M | 0.02% |
494,600
+94,400
| +24% | +$2.74M |
|
971
BWX Technologies
BWXT
$15.8B
| $14.9M | 0.02% |
375,100
-26,900
| -7% | -$1.05M |
|
972
Westwood Holdings Group
WHG
$183M
| $14.8M | 0.02% |
247,500
+23,000
| +10% | +$1.3M |
|
|
CUDA
973
DELISTED
Barracuda Networks, Inc.
CUDA
| $14.8M | 0.02% |
692,200
+141,000
| +26% | +$3.29M |
|
974
Otter Tail
OTTR
$3.87B
| $14.8M | 0.02% |
362,900
+74,900
| +26% | +$2.78M |
|
975
Chesapeake Utilities
CPK
$3.25B
| $14.8M | 0.02% |
221,000
-16,900
| -7% | -$1.08M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.